Toronto Dominion Bank
EW icon

Toronto Dominion Bank’s Edwards Lifesciences EW Stock Holding History

Toronto Dominion Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Sell
213,373
-128,909
-38% -$10.6M 0.02% 473
2025
Q4 		$29.2M Buy
342,282
+126,337
+59% +$10.4M 0.04% 360
2025
Q3 		$16.8M Sell
215,945
-60,273
-22% -$4.71M 0.03% 485
2025
Q2 		$21.6M Buy
276,218
+12,811
+5% +$955K 0.04% 365
2025
Q1 		$19.1M Sell
263,407
-53,919
-17% -$3.86M 0.04% 339
2024
Q4 		$23.5M Buy
317,326
+17,046
+6% +$1.19M 0.04% 317
2024
Q3 		$19.8M Buy
300,280
+4,008
+1% +$291K 0.04% 313
2024
Q2 		$27.4M Sell
296,272
-60,504
-17% -$5.36M 0.04% 254
2024
Q1 		$34.1M Buy
356,776
+6,968
+2% +$585K 0.05% 225
2023
Q4 		$26.7M Buy
349,808
+28,261
+9% +$1.97M 0.04% 309
2023
Q3 		$22.3M Sell
321,547
-10,941
-3% -$879K 0.04% 315
2023
Q2 		$31.3M Buy
332,488
+839
+0.3% +$72.9K 0.05% 266
2023
Q1 		$27.4M Sell
331,649
-74
-0% -$5.82K 0.04% 261
2022
Q4 		$24.7M Buy
331,723
+55,809
+20% +$4.3M 0.04% 290
2022
Q3 		$22.8M Sell
275,914
-44,003
-14% -$4.23M 0.04% 278
2022
Q2 		$30.4M Sell
319,917
-50,680
-14% -$5.25M 0.06% 197
2022
Q1 		$43.6M Sell
370,597
-197,301
-35% -$22.1M 0.07% 164
2021
Q4 		$73.6M Buy
567,898
+278,505
+96% +$32.5M 0.1% 137
2021
Q3 		$32.8M Buy
289,393
+16,448
+6% +$1.88M 0.05% 202
2021
Q2 		$28.3M Sell
272,945
-35,392
-11% -$3.34M 0.04% 245
2021
Q1 		$25.8M Sell
308,337
-83,586
-21% -$7.07M 0.05% 225
2020
Q4 		$35.8M Buy
391,923
+41,706
+12% +$3.46M 0.07% 186
2020
Q3 		$28M Sell
350,217
-57,826
-14% -$4.51M 0.07% 180
2020
Q2 		$28.2M Sell
408,043
-64,424
-14% -$4.58M 0.07% 191
2020
Q1 		$29.7M Sell
472,467
-260,178
-36% -$18.8M 0.09% 167
2019
Q4 		$57M Buy
732,645
+272,991
+59% +$21.3M 0.1% 144
2019
Q3 		$33.7M Sell
459,654
-471,186
-51% -$33.1M 0.07% 187
2019
Q2 		$28.7M Buy
930,840
+497,001
+115% +$30.1M 0.06% 210
2019
Q1 		$27.7M Buy
433,839
+59,205
+16% +$3.38M 0.04% 229
2018
Q4 		$19.1M Sell
374,634
-34,101
-8% -$1.73M 0.03% 250
2018
Q3 		$23.7M Buy
408,735
+2,463
+0.6% +$120K 0.04% 243
2018
Q2 		$19.7M Buy
406,272
+66,303
+20% +$3.09M 0.04% 279
2018
Q1 		$15.8M Buy
339,969
+66,552
+24% +$2.89M 0.04% 291
2017
Q4 		$10.3M Buy
273,417
+33,297
+14% +$1.22M 0.03% 333
2017
Q3 		$8.75M Buy
240,120
+26,802
+13% +$1.02M 0.03% 336
2017
Q2 		$8.41M Buy
213,318
+41,241
+24% +$1.51M 0.03% 323
2017
Q1 		$5.39M Buy
172,077
+61,488
+56% +$1.93M 0.01% 381
2016
Q4 		$3.45M Buy
110,589
+91,965
+494% +$2.98M 0.01% 386
2016
Q3 		$748K Buy
18,624
+15,084
+426% +$568K ﹤0.01% 497
2016
Q2 		$118K Sell
3,540
-1,401
-28% -$47.9K ﹤0.01% 670
2016
Q1 		$145K Sell
4,941
-14,895
-75% -$411K ﹤0.01% 624
2015
Q4 		$522K Sell
19,836
-708
-3% -$18.4K ﹤0.01% 511
2015
Q3 		$487K Buy
20,544
+2,736
+15% +$66K ﹤0.01% 513
2015
Q2 		$423K Buy
17,808
+12
+0.1% +$271 ﹤0.01% 587
2015
Q1 		$423K Sell
17,796
-8,688
-33% -$195K ﹤0.01% 575
2014
Q4 		$562K Buy
26,484
+14,472
+120% +$291K ﹤0.01% 556
2014
Q3 		$205K Buy
12,012
+72
+0.6% +$1.14K ﹤0.01% 611
2014
Q2 		$171K Buy
11,940
+1,668
+16% +$22.6K ﹤0.01% 768
2014
Q1 		$127K Sell
10,272
-204
-2% -$2.35K ﹤0.01% 808
2013
Q4 		$115K Buy
+10,476
New +$118K ﹤0.01% 791

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Toronto Dominion Bank's EW Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Edwards Lifesciences (EW) stake by 38% in Q1 2026, selling an estimated $10.6M and leaving 213,373 shares worth $17.1M. The position accounts for 0.02% of the portfolio, ranked #473.

Toronto Dominion Bank first reported a position in EW in Q4 2013 and has held it in 50 quarters since. The position peaked at $73.6M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Toronto Dominion Bank held 213,373 shares of Edwards Lifesciences worth $17.1M as of Q1 2026.
  • Toronto Dominion Bank sold 128,909 Edwards Lifesciences shares in Q1 2026, an estimated $10.6M.
  • Edwards Lifesciences made up 0.02% of Toronto Dominion Bank's portfolio in Q1 2026, its #473 holding.
  • Toronto Dominion Bank first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 50 quarters since.
  • Toronto Dominion Bank's Edwards Lifesciences position peaked at $73.6M in Q4 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.